PCA3 and prostate carcinoma: These paradoxical findings are consistent with several early studies (Salagierski et al., 2010; Balcerczak et al., 2003) and in particular with a recent tissue-based study of PCA3 expression in prostate cancer (Alshalalfa et al., 2017).